| UniProt ID | BAP18_HUMAN | |
|---|---|---|
| UniProt AC | Q8IXM2 | |
| Protein Name | Chromatin complexes subunit BAP18 | |
| Gene Name | BAP18 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 172 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | Component of chromatin complexes such as the MLL1/MLL and NURF complexes.. | |
| Protein Sequence | MTSASTKVGEIFSAAGAAFTKLGELTMQLHPVADSSPAGAKWTETEIEMLRAAVKRFGDDLNHISCVIKERTVAQIKATVKRKVYEDSGIPLPAESPKKGPKKVASGVLSPPPAAPPPSSSSVPEAGGPPIKKQKADVTLSALNDSDANSDVVDIEGLGETPPAKKLNFDQA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 26 (in isoform 2) | Phosphorylation | - | 9.89 | 20873877 | |
| 26 | Phosphorylation | FTKLGELTMQLHPVA HHHHHHHHEEEEECC | 9.89 | 27794612 | |
| 27 | Sulfoxidation | TKLGELTMQLHPVAD HHHHHHHEEEEECCC | 6.62 | 21406390 | |
| 35 | Phosphorylation | QLHPVADSSPAGAKW EEEECCCCCCCCCCC | 28.60 | 23401153 | |
| 35 (in isoform 2) | Phosphorylation | - | 28.60 | 30266825 | |
| 36 | Phosphorylation | LHPVADSSPAGAKWT EEECCCCCCCCCCCC | 21.22 | 22167270 | |
| 36 (in isoform 2) | Phosphorylation | - | 21.22 | 30266825 | |
| 41 | Ubiquitination | DSSPAGAKWTETEIE CCCCCCCCCCHHHHH | 54.45 | 29967540 | |
| 43 | Phosphorylation | SPAGAKWTETEIEML CCCCCCCCHHHHHHH | 32.11 | 26074081 | |
| 45 | Phosphorylation | AGAKWTETEIEMLRA CCCCCCHHHHHHHHH | 34.58 | 26074081 | |
| 62 | Phosphorylation | KRFGDDLNHISCVIK HHHCCCCCCCEEEEE | 37.12 | 32645325 | |
| 69 | Ubiquitination | NHISCVIKERTVAQI CCCEEEEECCCHHHH | 22.27 | 32015554 | |
| 69 | Acetylation | NHISCVIKERTVAQI CCCEEEEECCCHHHH | 22.27 | 23749302 | |
| 76 | Phosphorylation | KERTVAQIKATVKRK ECCCHHHHHHHHCCH | 2.06 | 32142685 | |
| 77 | Ubiquitination | ERTVAQIKATVKRKV CCCHHHHHHHHCCHH | 26.40 | 32015554 | |
| 77 | Acetylation | ERTVAQIKATVKRKV CCCHHHHHHHHCCHH | 26.40 | 25953088 | |
| 85 | Phosphorylation | ATVKRKVYEDSGIPL HHHCCHHHCCCCCCC | 19.63 | 22167270 | |
| 88 | Phosphorylation | KRKVYEDSGIPLPAE CCHHHCCCCCCCCCC | 27.04 | 22167270 | |
| 96 | Phosphorylation | GIPLPAESPKKGPKK CCCCCCCCCCCCCCC | 44.09 | 19664994 | |
| 96 (in isoform 3) | Phosphorylation | - | 44.09 | 24719451 | |
| 106 | Phosphorylation | KGPKKVASGVLSPPP CCCCCCCCCCCCCCC | 32.21 | 23401153 | |
| 106 (in isoform 3) | Phosphorylation | - | 32.21 | 27251275 | |
| 110 | Phosphorylation | KVASGVLSPPPAAPP CCCCCCCCCCCCCCC | 32.71 | 23401153 | |
| 110 (in isoform 3) | Phosphorylation | - | 32.71 | 24719451 | |
| 112 | Phosphorylation | ASGVLSPPPAAPPPS CCCCCCCCCCCCCCC | 27.99 | 32142685 | |
| 119 | Phosphorylation | PPAAPPPSSSSVPEA CCCCCCCCCCCCCCC | 48.93 | 23927012 | |
| 119 | O-linked_Glycosylation | PPAAPPPSSSSVPEA CCCCCCCCCCCCCCC | 48.93 | 21740066 | |
| 120 | Phosphorylation | PAAPPPSSSSVPEAG CCCCCCCCCCCCCCC | 32.19 | 23927012 | |
| 121 | Phosphorylation | AAPPPSSSSVPEAGG CCCCCCCCCCCCCCC | 39.43 | 25159151 | |
| 122 | Phosphorylation | APPPSSSSVPEAGGP CCCCCCCCCCCCCCC | 43.57 | 23927012 | |
| 127 | Phosphorylation | SSSVPEAGGPPIKKQ CCCCCCCCCCCCCCC | 47.69 | 32142685 | |
| 131 | Ubiquitination | PEAGGPPIKKQKADV CCCCCCCCCCCCCCE | 11.09 | 32015554 | |
| 132 | Acetylation | EAGGPPIKKQKADVT CCCCCCCCCCCCCEE | 55.73 | 25953088 | |
| 139 | Phosphorylation | KKQKADVTLSALNDS CCCCCCEEEECCCCC | 18.62 | 20873877 | |
| 141 | Phosphorylation | QKADVTLSALNDSDA CCCCEEEECCCCCCC | 22.73 | 28355574 | |
| 146 (in isoform 3) | Phosphorylation | - | 37.23 | 24719451 | |
| 146 | Phosphorylation | TLSALNDSDANSDVV EEECCCCCCCCCCCC | 37.23 | 30266825 | |
| 150 (in isoform 3) | Phosphorylation | - | 33.24 | 24719451 | |
| 150 | Phosphorylation | LNDSDANSDVVDIEG CCCCCCCCCCCCEEC | 33.24 | 30266825 | |
| 161 (in isoform 3) | Phosphorylation | - | 32.54 | 24719451 | |
| 161 | Phosphorylation | DIEGLGETPPAKKLN CEECCCCCCCCHHCC | 32.54 | 30266825 | |
| 165 | Ubiquitination | LGETPPAKKLNFDQA CCCCCCCHHCCCCCC | 64.66 | 32015554 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 96 | S | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BAP18_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BAP18_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| RBBP4_HUMAN | RBBP4 | physical | 20850016 | |
| HMGX4_HUMAN | HMGXB4 | physical | 20850016 | |
| BPTF_HUMAN | BPTF | physical | 20850016 | |
| SMCA5_HUMAN | SMARCA5 | physical | 20850016 | |
| SMCA1_HUMAN | SMARCA1 | physical | 20850016 | |
| RBBP7_HUMAN | RBBP7 | physical | 20850016 | |
| GRP75_HUMAN | HSPA9 | physical | 20850016 | |
| LMNB1_HUMAN | LMNB1 | physical | 20850016 | |
| HSP7C_HUMAN | HSPA8 | physical | 20850016 | |
| LMNA_HUMAN | LMNA | physical | 20850016 | |
| BPTF_HUMAN | BPTF | physical | 26496610 | |
| S38A5_HUMAN | SLC38A5 | physical | 26496610 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-96, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-96, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-36, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-96, AND MASSSPECTROMETRY. | |
| "Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-96, AND MASSSPECTROMETRY. | |
| "A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-96, AND MASSSPECTROMETRY. | |